Lombardia Capital Partners’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1.69M Sell
72,134
-444,470
-86% -$11M 1.53% 15
2016
Q4
$13M Sell
516,604
-17,577
-3% -$444K 1.33% 28
2016
Q3
$15M Sell
534,181
-138,005
-21% -$3.54M 1.02% 30
2016
Q2
$16.6M Sell
672,186
-167,450
-20% -$4.16M 1.09% 26
2016
Q1
$18.6M Buy
839,636
+721,842
+613% +$19.2M 0.96% 35
2015
Q4
$4.12M Sell
117,794
-152,874
-56% -$4.79M 0.21% 120
2015
Q3
$7.71M Sell
270,668
-207,356
-43% -$6.97M 0.37% 101
2015
Q2
$15.9M Sell
478,024
-416,254
-47% -$12.8M 0.54% 77
2015
Q1
$25.2M Buy
+894,278
New +$22.2M 0.76% 43

Other funds holding PMC

Lombardia Capital Partners's PMC Position: Q1 2017 in Review

Lombardia Capital Partners reduced its PharMerica Corporation (PMC) stake by 86% in Q1 2017, selling an estimated $11M and leaving 72,134 shares worth $1.69M. The position accounts for 1.53% of the portfolio, ranked #15.

Lombardia Capital Partners first reported a position in PMC in Q1 2015 and has held it in 9 quarters since. The position peaked at $25.2M in Q1 2015. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

  • Lombardia Capital Partners held 72,134 shares of PharMerica Corporation worth $1.69M as of Q1 2017.
  • Lombardia Capital Partners sold 444,470 PharMerica Corporation shares in Q1 2017, an estimated $11M.
  • PharMerica Corporation made up 1.53% of Lombardia Capital Partners's portfolio in Q1 2017, its #15 holding.
  • Lombardia Capital Partners first reported a position in PharMerica Corporation in Q1 2015 and has held it in 9 quarters since.
  • Lombardia Capital Partners's PharMerica Corporation position peaked at $25.2M in Q1 2015.
  • 152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Lombardia Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.